Professor Jens K. Habermann, M.D., PH.D., is Director General of BBMRI-ERIC (Biobanking and Biomolecular Resources Research Infrastructure – European Research Infrastructure Consortium) since September 2020 and Professor at the University of Lübeck. Prof. Habermann obtained his M.D. training at the Medical University of Lübeck (Lübeck, Germany), received his Ph.D. at the Cancer Center Karolinska, Karolinska Institute (Stockholm, Sweden) and a Postdoctoral Fellowship at the National Cancer Institute, NIH (Bethesda, USA). As board certified specialist in human genetics, Prof. Habermann combines clinics, biobanking, and translational (cancer) research to optimize personalised medicine. Prof. Habermann was actively involved in the Molecular Tumor Board as part of the precision medicine program in Lübeck. Prof. Habermann was President of ESBB (European, Middle Eastern & African Society for Biopreservation & Biobanking; esbb.org) from 2018 to 2020 and board member of GBN/GBA (German Biobank Node and German Biobank Alliance; bbmri.de). Prof. Habermann received more than 15 scientific awards, holds about 10 patents and patent applications, is reviewer and editorial board member of more than 25 scientific journals and member of numerous scientific societies. He has a translational cancer research and biobanking related publication track record and was principal investigator and co-PI in more than 25 national and European grant projects.

How BBMRI-ERIC structures the European Research Area on examples of Cancer Mission, EOSC Federation and Personalized Medicine